2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: General Considerations - 2
Date: Tuesday, June 5, 2018
Time: 4:30pm-6:00pm
Location: Room 6A
Session Type: Concurrent Session
Meeting: 2018 American Transplant Congress
- 4:54pm-5:06pm
Efficacy and Safety of Bleselumab in Kidney Transplant Recipients: A Phase 2, Randomized, Open-Label Study
- 5:18pm-5:30pm
RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance
« View all sessions from the 2018 American Transplant Congress